Notice of Intent to Sole Source Synthetic Preimplantation Factor (sPIF)
Closed Special Notice Posted
- Solicitation number
- HT9425-24-Q-0097
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Silver Spring, Maryland 20910, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Army Medical Research Acquisition Activity (USAMRAA), in support of the Walter Reed Army Institute of Research (WRAIR), has published a Special Notice to negotiate solely with BioIncept LLC to provide the synthetic form of Preimplantation Factor (sPIF) for WRAIR's Blast Induced Neurotrauma Branch's study on the efficacy of sPIF. The North American Industry Classification System (NAICS) for this requirement is 541715, with a size standard of 1000.
The purpose of this Special Notice is to inform interested parties that USAMRAA intends to negotiate solely with BioIncept LLC, as the sPIF required for this study is developed and synthesized by BioIncept LLC and is not available through any other source. The key deadline for interested parties to respond in writing with clear and convincing evidence of their ability to provide the required items is 12:00 PM ET on July 26, 2024. This Special Notice is not a request for competitive quotes, and the information received will be used to determine whether a competitive procurement is in the best interest of the Government.
Notice text
The U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of the Walter Reed Army Institute of Research (WRAIR) intends to negotiate solely (as prescribed in FAR 13.106(b)(1)(i)) with BioIncept LLC,5496 Winding Cape Way, Mason OH, 45040, to provide the synthetic form of Preimplantation Factor (sPIF), for WRAIR’s Blast Induced Neurotrauma Branch’s (BINT) study on the efficacy of sPIF by data interpretation/analysis, preparation of quarterly reports, annual progress reports, manuscripts, and final project report. The sPIF required for this study, is developed and synthesized by BioIncept LLC and is not available through any other source.
The North American Industry Classification System (NAICS) for this requirement is 541715 and the size standard is 1000.
This announcement constitutes the only notice by the government; a written solicitation will not be issued. All sources that believe they are eligible to provide these items must respond in writing. Responses must be supported with clear and convincing evidence to clearly articulate the ability to provide the items outlined above. A request for documentation will not be considered an affirmative response. This Special Notice of Intent is not a request for competitive quotes. Information received will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. If no written responses are received by the date listed below, the purchase will be awarded without further remark. All questions and responses concerning this notice shall be emailed to Ms. Dawn Jennings at dawn.v.jennings.civ@health.mil.
Interested concerns must identify their capability in writing to the above e-mail address or by mail to the address listed below no later than 12:00PM ET, July 26, 2024. Contracting Office Address:
US Army Medical Research Acquisition Activity, ATTN: FCMR-ACO-AA, 808 Schreider Street, Frederick, MD 21702-5014
Point of Contact:
Dawn Jennings
Dawn.v.jennings.civ@health.mil
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity